Header graphic for print
Focus on Regulation

Tag Archives: social media

#Ad and the challenges of native advertising and social influencers

Westminster Media Forum recently hosted a seminar to discuss native advertising and social influencer marketing and their measurement, regulation and impact on brands. Industry insiders, advertising agencies, content producers, publishers, influencers and regulators joined forces to discuss the challenges faced by these new models of advertising. Central to these latest trends is the shift in

Antitrust in WeChat times

This post was contributed by Qing Lyu. WeChat is a very popular messaging app in China, similar to WhatsApp and Facebook Messaging in other parts of the world. It has social networking, gaming, e-commerce and mobile payment functionalities.  The app plays an increasingly important role in social – and business – interactions in China.  As

Hogan Lovells Client Alert Highlights Considerations for Contractors in Wake of New Procurement Rule Limiting Terms of Service for Online Social Media Applications

On June 25, Hogan Lovells’ Government Contracts Practice published a client alert on the June 21 interim rule amending the Federal Acquisition Regulation (“FAR”) by preventing federal agencies from agreeing to terms of service (“TOS”) agreements and End User License Agreements (“EULAs”) with open-ended indemnification clauses.  Through the interim rule, President Obama’s Administration is attempting

SEC Clarifies Stance on Social Media Disclosures

The SEC has issued a report clarifying that companies can use social media to announce key information without violating Regulation FD, provided they alert investors about which social media outlets they will use for their disclosures.  The SEC report stems from an investigation into a 43-word message that the CEO of Netflix, Reed Hastings, posted on

FDA’s Unsolicited Requests Docket is Closed – 35 Commenters address various issues, including First Amendment

As discussed in our earlier post, FDA solicited comments in a Federal Register notice on its “Draft Guidance for Industry: Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Devices.”  See 76 Fed. Reg. 82303 (December 30, 2011). As of March 29, 2012, the docket is technically closed.  The docket features 35 comments submitted by biopharmaceutical companies, trade organizations, and

Industry Waits for Some Signal That FDA Will Rethink Its Proposed Approach to Unsolicited Requests

With the comment period closed, industry stakeholders wait for some indication that FDA will rethink its approach to responding to unsolicited requests, as set forth in FDA’s draft guidance, Guidance For Industry – Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices.  Since release of the draft in December 2011, stakeholder

Hogan Lovells Comments on the FDA’s “Draft Guidance on Responding to Unsolicited Requests”

The FDA issued its Draft “Guidance for Industry: Responding to Unsolicited Requests for Off-label Information About Prescription Drugs and Medical Devices” in December 2011.  As our FDA group follows these issues closely on behalf of the industry, we filed a Comment on this draft guidance encouraging the agency to reconsider and clarify certain elements of the Draft Guidance,